The Disruptive Reality of Child Transition
At 12 I was put on puberty blockers, testosterone at 13, and had a double mastectomy a month later. No one asked why I was hurting—just ‘affirmed’ me. Now I’m 18, scarred, infertile, and suing the doctors who sold me a cure that left me worse.
Overview
Layla Jane, now 18, was fast-tracked through medical transition at 12—puberty blockers, testosterone, and a double mastectomy at 13—after doctors framed it as the only cure for her distress. She recounts unmanaged anxiety, isolation, and online fandoms that primed her to see transition as an escape, leaving her with permanent physical harm and no follow-up care. Now detransitioned, she is suing Kaiser Permanente to stop other children from being rushed into irreversible interventions.
Full Video Summary
Layla Jane, now 18, describes beginning medical transition at only 12 years old: within a single year she was started on puberty blockers (Lupron), then testosterone, and underwent a double mastectomy one month after turning 13. Speaking with fellow detransitioner Chloe Cole, she recounts how she was “sold something that was going to help me… only to come out on the other side not feeling any better.” Layla emphasizes that she was in no condition to consent: she had unmanaged anxiety, no understanding of female anatomy or future fertility, and was told—outside her presence—that refusing transition would increase her suicide risk. Doctors framed the process as the only treatment for “gender dysphoria,” never mentioning desistance rates, alternative therapies, or the possibility of growing out of distress. The interview details how social isolation and online fandom spaces primed her to see transition as an escape. Precocious puberty at nine left her body developing before peers; social media algorithms then fed her transgender content that promised self-discovery and relief from female expectations. She recalls being a tomboyish only child who struggled with peers, was bullied, and never received screening for autism or other comorbidities. Once socially transitioning in sixth grade, harassment intensified and she was pulled from public school; the subsequent loneliness and lack of female friendships, she believes, further fueled the desire to “become a boy.” Layla outlines the physical and emotional toll: Lupron induced menopause-like hot flashes at 12; testosterone caused rapid voice drop, body hair, mood swings, and emotional numbing. Binding for up to 18 hours a day led to rib pain, breathing problems, and overheating. After detransitioning—first quietly tapering testosterone at 17, then socially reverting at 18—she was left with permanent changes including a deeper voice, possible joint issues, and chronic nerve pain/numbness across her chest that causes nightly itching spells. She never received guidance on tapering hormones or potential reconstruction, and Kaiser Permanente never followed up when she stopped appointments. Motivated by Chloe Cole’s lawsuit, Layla is now suing Kaiser and the physicians who treated her, aiming to impose “checks and balances” so that no other child is rushed into irreversible interventions. She closes by acknowledging both grief and resilience: while she “can’t ever undo” what was done, she has re-established a stable relationship with her family, holds a job, and is cautiously looking toward an uncertain but “exciting and scary” future.